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The nucleocapsid (N) protein of bovine respiratory syncytial virus (BRSV) is a multifunctional protein that plays a central
role in transcription and replication of viral genomic RNA. To investigate the domains and specific residues involved in
different N activities, we generated a total of 27 deletion and 12 point mutants of the N protein. These mutants were
characterized using an intracellular BRSV-CAT minigenome replication system for the ability to (1) direct minigenome RNA
synthesis, (2) direct minigenome encapsidation, and (3) form a complex with the phosphoprotein (P). The mutations tested
were defective in synthesis of RNA from the BRSV-CAT minigenome template with the exception of the following: a deletion
involving the first N-terminal amino acid and mutations involving conservative substitution at the second amino acid and at
certain internal cysteine residues. Micrococcal nuclease enzyme protection assays showed that mutations involving amino
acids 1–364 of the 391-amino-acid N protein prevented minigenome encapsidation. Thus the BRSV N protein has a
C-terminal, 27-amino-acid tail that is not required for encapsidation. Interestingly, two of the mutations that ablated
encapsidation did not greatly affect RNA synthesis; the mutant involving deletion of the N-terminal amino acid and the mutant
involving a substitution at position 2. This finding indicates that the formation of a nucleocapsid sufficient to protect the RNA
from nuclease is not required for template function. Coimmunoprecipitation of N and P using N- or P-specific antiserum
revealed two regions of the N protein that are important for association with the P protein: a central portion of 244–290 amino
acids and a C-terminal portion of 338–364 amino acids. © 2000 Academic PressINTRODUCTION
Bovine respiratory syncytial virus (BRSV) is a major
cause of respiratory disease in calves, resulting in sub-
stantial economic losses to the cattle industry
(Bohlender et al., 1982; Stott et al., 1980; Stott and Taylor,
1985). BRSV is an enveloped RNA virus that along with
human respiratory syncytial virus (HRSV), pneumonia
virus of mice (PVM), and avian pneumovirus (APV) be-
longs to the genus Pneumovirus of the family Paramyxo-
viridae. BRSV and HRSV are similar in gene and protein
compositions and are antigenically related at the level of
nucleocapsid (N), phosphoprotein (P), matrix (M), and
fusion (F) proteins (Lerch et al., 1989; Mallipeddi et al.,
1990), with the major antigenic difference in the attach-
ment glycoprotein (G) (Lerch et al., 1989; Orvell et al.,
1987; Taylor et al., 1984).
Similar to HRSV, the BRSV genome consists of a sin-
gle-stranded negative-sense RNA approximately 15 kb in
length. The BRSV genome encodes 11 proteins (Lerch et
al., 1989; Mallipeddi et al., 1990). Four proteins are asso-1 To whom reprint requests should be addressed. Fax: (301) 935-
079. E-mail: ss5@umail.umd.edu.
215ciated with the genomic RNA, namely N, P, the large
polymerase (L) protein, and the transcription antitermi-
nation factor M2-1. Three proteins are transmembrane
components of the envelope: F, G, and the small hydro-
phobic (SH) proteins. The M protein is an inner virion
protein. NS1 and NS2 are nonstructural proteins. In ad-
dition, we have found (Samal et al., unpublished data)
that BRSV has an M2-2 protein, which is encoded in a
second open reading frame (ORF) in the M2 mRNA, as
has been described recently for HRSV (Bermingham and
Collins, 1999).
The N protein encapsidates the genomic RNA, which
constitutes the nucleocapsid, and this serves as the
functional template for replication and transcription
(Barik, 1992). The N-RNA nucleocapsid together with the
N, P, M2-1, and L proteins, compose the ribonucleopro-
tein complex (RNP), which is required for transcription
and replication (Collins et al., 1996). During transcription,
gene start and end signals on the viral genome are
recognized, and 10 capped and polyadenylated mRNAs
are produced. Replication, on the other hand, results in
an encapsidated, full-length antigenomic RNA. It is not
completely understood how the switch between tran-
scription and replication occurs. Studies with Sendai and
0042-6822/00 $35.00
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216 KHATTAR ET AL.vesicular stomatitis viruses suggest that the polymerase
complex (P/L) is required for both transcription and rep-
lication, whereas replication requires an additional com-
plex composed of unassembled N and P proteins (Cur-
ran et al., 1991; Horikami et al., 1992).
The N protein is highly conserved among pneumovi-
ruses. The BRSV N protein, which is 391 amino acids
long, has 93% and 95% amino acid sequence identity
with HRSV and PVM, respectively (Barr et al., 1991; Samal
et al., 1991). Comparison of the pneumovirus N protein
with its counterparts in other paramyxoviruses and rhab-
doviruses identified three short regions that exhibit re-
latedness within the virus family and similarity between
different families (Barr et al., 1991). One region is located
in the carboxyl-terminal half of the protein (amino acids
277–326 of the BRSV N protein), and the two short hy-
drophobic regions are located within the internal region
of the protein (amino acids 160–172 and 250–262 of the
BRSV N protein). These regions are hypothesized to be
involved in RNA binding and protein–protein interactions.
The N protein does not contain any of the canonical
consensus RNA binding motifs found in the other RNA
binding proteins (Burd and Dreyfuss, 1994).
The N protein is a multifunctional protein that plays a
central role in paramyxovirus replication. Localization of
domains responsible for N–RNA and N–P interactions is
important for understanding the transcription and repli-
cation events in the life cycle of paramyxoviruses. Pre-
viously, using an in vitro protein-blotting protein overlay
technique, the BRSV N protein was shown to interact
with the P protein (Samal et al., 1993). Using a yeast
two-hybrid system, the BRSV N protein was shown to
interact with both itself and the P protein (Krishnamurthy
and Samal, 1998). However, these systems might not
reflect the true protein–protein interactions occurring in
virus-infected cells. Recently, we developed a system in
which a BRSV minigenome containing the chloramphen-
icol acetyltransferase (CAT) gene is transcribed and rep-
licated intracellularly by BRSV proteins N, P, and L sup-
plied in trans from plasmids driven by vaccinia virus T7
RNA polymerase (Yunus et al., 1998). In this communica-
tion, we used this system to identify the regions of the N
protein involved in transcription, replication, and encap-
sidation of viral RNA. We also report the interactions of N
and P proteins by coimmunoprecipitation, using N- and
P- specific antisera.
RESULTS
Mutagenesis strategy
Deletion mutations were introduced at various sites
throughout the 391-amino-acid N protein (Fig. 1). In ad-
dition, we made amino acid substitutions involving con-
served leucine residues present at positions 2 and 391
(Fig. 2). Some of the substitutions involved drastic
changes (lysine or glutamic acid), whereas others wereconservative (alanine or glycine). We also substituted
cysteine residues with serine residues (chosen to pre-
serve the size and character of the residue) at positions
48, 156, or 162 or simultaneously at positions 156 and 162
(Fig. 2). The latter two cysteine residues are conserved
among pneumoviruses. A total of 27 deletion and 12
substitution mutations were made. As described later,
we then analyzed the activity of these N protein mutants
in transcription, replication, encapsidation, and interac-
tion with the P protein.
Mutations affecting minigenome transcription and
replication
We previously described a system in which a plasmid-
synthesized negative-sense BRSV minigenome contain-
ing the CAT gene is transcribed and replicated by BRSV
N, P, and L proteins supplied in trans from plasmids,
using the vaccinia virus/T7 RNA polymerase expression
system (Yunus et al., 1998). To evaluate the N protein
mutations, cells were infected with a vaccinia-T7 RNA
polymerase recombinant virus and transfected with plas-
mids encoding the BRSV minigenome, the P and L pro-
teins, and mutant or wild-type N protein. In this study, the
M2-1 protein was not included because a short gene,
such as CAT, can be transcribed with reasonable effi-
ciency in its absence (Fearns and Collins, 1999). Cells
were harvested at 48 h posttransfection. One of the
aliquot of each harvest was analyzed by CAT assay to
monitor gene expression (Fig. 3), and another aliquot
was processed to purify total intracellular RNA. The RNA
was analyzed by Northern blot hybridization using a
negative-sense RNA probe that would detect the posi-
tive-sense mRNA and the antigenome encoded by the
plasmid-supplied minigenome (Fig. 4).
In preliminary control experiments, with immunopre-
cipitation and Western blot assays, we confirmed that
each of the mutant proteins accumulated intracellularly
to a level comparable to that of the wild-type N protein;
thus, the effects described later were not due to differ-
ences in expression or stability of the various mutant N
proteins (see Figs. 9 and 10). In all of the minigenome
experiments, there was a very close correlation between
the level of CAT activity and the accumulation of positive-
sense mRNA and antigenome encoded by the plasmid-
supplied minigenome (Figs. 3 and 4).
Each N protein mutant was evaluated for its ability
to support CAT gene expression and RNA synthesis
from the plasmid-supplied minigenome. Based on the
level of CAT activity and the accumulation of positive-
sense CAT-specific RNA, the mutants of N protein
could be classified into four different categories, as
shown in Table 1: (I) mutations that did not affect N
protein function (CAT activity, and the amount of CAT
RNA between 50% and 100% of that obtained with wild
type N), (II) mutations that moderately reduced N pro-
in this
he C te
B
a
(
217ANALYSIS OF BRSV NUCLEOCAPSID PROTEINtein function (CAT activity, and the amount of CAT RNA
between 20% and 50%), (III) mutations that drastically
reduced function of N protein (CAT activity, and the
amount of CAT RNA between 2% and 20%), and (IV)
mutations that completely inhibited N protein function
FIG. 1. Diagram of the deletion mutants of the BRSV N protein used
acids either at the N terminus (NN), at an internal region (NID), or at t
FIG. 2. Diagram of the single- and double-point mutations of the
RSV N protein used in this study. The substitution of leucine (L) to
lanine (A), glycine (G), lysine (K) or glutamic acid (E) and of cysteine
C) to serine (S) is shown.(CAT activity, and the amount of CAT RNA less than
2%). As shown in Table 1 and Figs. 3 and 4, most of the
mutations greatly reduced or ablated minigenome CAT
expression and RNA synthesis. Removal of the first
amino acid from the N terminus had minimal effect
(Figs. 3A and 4A, lane 5), whereas the removal of two,
three, four, or eight amino acids from the N terminus
was very inhibitory (lanes 6–9). Removal of the last
amino acid from the C terminus reduced activity by
20-fold, and all the larger C-terminal deletions com-
pletely inhibited N protein function (Figs. 3A and 4A,
lanes 10 and 11). Eight internal deletions of 47 amino
acids each were made, which spanned the remainder
of the molecule (mutants NIDD9-55, NIDD56-102,
NIDD103-149, NIDD150-196, NIDD197-243, NIDD244-
290, NIDD291-337, and NIDD338-384, shown schemat-
ically in Fig. 1). All of these internal deletion mutants
completely inhibited N protein function as revealed by
study. The names of the mutant N proteins indicate the deleted amino
rminus (NC), with the remaining sequences shown as the solid bars.CAT expression and RNA synthesis (Figs. 3B and 4B,
lanes 1–8). These results suggest that all regions of
(
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218 KHATTAR ET AL.the N protein, except the first amino acid at the N
FIG. 3. Gene expression by the BRSV-CAT minigenome as detected
(MVA-T7) and transfected with plasmids encoding the BRSV-CAT minig
0.2 mg), and L protein (0.1 mg). At 48 h posttransfection, cells were harv
f excised spots. The results are expressed as percent acetylation rela
00%. As negative controls, the cells in lanes 2–4 in panel A did not rterminus, are essential for minigenome RNA synthesis
and CAT expression.Substitution mutations involving the conserved leucine
T assay. Subconfluent HEp-2 cells were infected with vaccinia virus
(0.4 mg), wild type (WT), or mutant BRSV N protein (0.4 mg), P protein
processed for CAT assay, and quantified by liquid scintillation counting
the positive control containing wild-type N protein (panel A, lane 1) as
plasmids encoding wild-type N, P, and L proteins, respectively.by CA
enome
ested,
tive toresidue present at position 2 of the N terminus or at
position 391 of the C terminus were evaluated for CAT
—Conti
219ANALYSIS OF BRSV NUCLEOCAPSID PROTEINexpression and RNA synthesis (Figs. 3 and 4). At position
2, the conservative changes of leucine to alanine or
glycine had minimal effect on the expression of CAT and
RNA synthesis (Fig. 3C, lanes 1 and 2, and Fig. 4C, lanes
2 and 3), whereas the nonconservative changes to lysine
or glutamic acid reduced activity by 5- and 20-fold, re-
spectively (Fig. 3C, lanes 3 and 4, and Fig. 4C, lanes 4
and 5). At the C-terminal position 391, each of the four
substitutions was highly inhibitory (Fig. 3C, lanes 5–8,
and Fig. 4C, lanes 6–9). These results suggest that the
leucine residue present at the C terminus (position 391)
is necessary for the function of N protein, whereas the
leucine residue at position 2 could be substituted by a
conservative amino acid.
The N protein mutations that involved changing the
cysteine to serine at positions 48, 156 or 162, or 156 and
162 together were also analyzed for CAT expression and
RNA synthesis (Figs. 3 and 4). The cysteine-to-serine
change at position 156 or 162 resulted in a moderate
decrease in CAT expression and RNA synthesis (Figs. 3B
and 4B, lanes 9 and 10). Substitution at position 48 was
more inhibitory, reducing CAT expression and RNA syn-
thesis by more than sixfold (Figs. 3B and 4B, lane 12),
and substitution at 156 and 162 together completely
inhibited CAT activity and RNA synthesis (Figs. 3B and
4B, lane 11). The finding that substitution of each of the
cysteine residues resulted in no more than a threefold to
sixfold loss of CAT activity indicates that no single cys-
teine is critical to N protein function. Nevertheless, these
FIG. 3residues are important, because the effect of the simul-
taneous substitution at positions 156 and 162 was muchgreater than would have been anticipated from the indi-
vidual effects.
Mutations affecting minigenome encapsidation
We examined the ability of the mutant N proteins to
encapsidate minigenome RNA by repeating the mini-
genome experiments described previously. However,
this time, the cells were lysed with nonionic detergent
and treated with micrococcal nuclease (MCN) to destroy
unencapsidated RNA. The remaining RNA was then pu-
rified and analyzed by Northern blotting with a positive-
sense CAT RNA probe that would detect minigenome
RNA. The mutants shown in Fig. 1 were analyzed, and
the results are shown in Fig. 5.
The removal of one, two, three, four, or eight amino
acids from the N terminus of the N protein ablated its
ability to encapsidate the minigenome (Fig. 5A, lanes
6–10). The finding that deletion of the first amino acid
ablated encapsidation was unexpected because this de-
letion had only a modest effect on CAT expression and
RNA synthesis, as described earlier. At the C terminus,
deletion of the last 1, 2, 7, 14, 21, 22, 23, 24, 25, 26, or 27
amino acids left encapsidation largely intact (Fig. 5B,
lanes 1–11), whereas deletion of the last 28 amino acids
completely ablated encapidation (lane 12). Each of the
eight internal deletion mutants of N protein failed to
encapsidate the minigenome (Fig. 5C, lanes 5–12).
These experiments showed that amino acids 1–364 of N
protein are required for encapsidation of genomic RNA,
nuedwhereas amino acids 365–391 are not required for en-
capsidation of genomic RNA.
i220 KHATTAR ET AL.In addition, the single- and double-point mutations
described earlier were tested for encapsidation of mini-
genome RNA. Substitution of the leucine at position 2
with alanine or glutamic acid blocked encapsidation (Fig.
5A, lanes 4 and 5), whereas substitution with glycine or
lysine (lanes 2 and 3) was tolerated. The finding that the
leucine-to-alanine substitution at position 2 blocked en-
capsidation was unexpected, because this mutation had
minimal effect on CAT expression and RNA synthesis.
Examination of the cysteine mutants showed that each of
the single substitutions at position 48, 156, or 162 was
able to encapsidate minigenomic RNA, albeit at reduced
FIG. 4. The synthesis of positive-sense RNA from the BLT delta 7
minigenome template as detected by Northern blot hybridization. From
the experiment described in the legend to Fig. 3, aliquots of harvested
cells were processed with TRIzol to purify total RNA, which was
analyzed by Northern blot hybridization with a negative-sense CAT RNA
probe. Quantification of RNA in each lane was done using a densitom-
eter and was expressed as a percentage of the positive control reac-
tion containing wild-type N (panel A, lane 1). As negative controls, the
cells in lanes 2–4 in panel A did not receive plasmids encoding
wild-type N, P, and L proteins, respectively.level, whereas 156/162 double mutant was inactive (Fig.
5C, lanes 1–4).
a
tEffect of NND1 and 2L3A mutants on replication of
the minigenome in reconstituted (replicating)
minigenome system and on encapsidation in
nonreplicating minigenome system
In the previous experiments, using BLT delta 7 mini-
genome construct, we were not able to determine the
effects of the N protein mutations on replication of the
minigenome because we were not able to resolve the
antigenome RNA and CAT mRNA in formaldehyde–1.5%
agarose gels. Detection of antigenome RNA was espe-
cially important for the two interesting mutants (NND1
and 2L3A). Therefore, the BLT delta 7 construct was
modified to generate SK 7 minigenome construct, which
encodes a subgenic CAT mRNA that could be easily
distinguished from the antigenome (Fig. 6). Transfections
were performed using SK 7 minigenome DNA and wild-
type or mutant N, P, and L support plasmids, as men-
tioned earlier. Total intracellular RNA was extracted and
analyzed by Northern blot hybridization using either a
positive-sense CAT riboprobe to detect the synthesis of
minigenome RNA or a negative-sense riboprobe to de-
tect the synthesis of antigenome RNA and subgenic CAT
mRNA (Fig. 7). Densitometric analysis of autoradio-
graphs of Northern blots indicated that mutant 2L3A
(Fig. 7, lane 2) appeared to function as efficiently as wild
type in genome, antigenome, and subgenic CAT mRNAs
synthesis, whereas mutant NND1 (lane 3) showed a
TABLE 1
Classification of BRSV N Protein Mutants Based on the Level of
CAT Activity and Accumulation of Positive Sense CAT RNA
Category
Relative CAT
activity/amount
of CAT RNAa Mutants
I 50–100% WTN, NND1, 2L3A, 2L3G
II 20–50% 156C3S, 162C3S
III 2–20% NCD1, 2L3K, 2L3E,
391L3A, 391L3K, 48C3S
IV ,2% NND2, NND3, NND4, NND8,
NIDD9-55, NIDD56-102,
NIDD103-149, NIDD150-196,
NIDD197-243, NIDD244-290,
NIDD291-337, NIDD338-384,
NCD2, NCD7, 391L3G,
391L3E, 156&162C3S
Note. HEp-2 cells were infected with vaccinia virus (MVA-T7) and
transfected with plasmid BLT delta 7 encoding BRSV-CAT minigenome
and plasmids encoding either wild-type or mutant N, L, and P proteins.
At 48 h posttransfection, cells were harvested and analysed for CAT
activity by CAT assay or positive sense CAT RNA by Northern blot
analysis using negative sense CAT riboprobe. Quantification of CAT
activity was done by liquid scintillation counting of excised spots or
CAT RNA was done by densitometry.
a The results depicted are the average values calculated from three
ndependent experiments. In each experiment, the CAT activity or the
mount of CAT RNA obtained with the wild-type BRSV N protein was
aken as 100%.
221ANALYSIS OF BRSV NUCLEOCAPSID PROTEINslight reduction in synthesis of genome, antigenome,
and subgenic CAT mRNAs. Mutant NND2 (Fig. 7, lane 4)
was negative for the synthesis of these RNAs. These
results indicate that deletion of N-terminal amino acid
and substitution of leucine with alanine at position 2 did
not affect the replication ability of these mutants.
To distinguish between encapsidation of vaccinia T7
RNA polymerase-derived negative-sense RNA and that
produced through BRSV RNA polymerase-directed repli-
cation via a positive-sense intermediate and to confirm
that NND1 and 2L3A mutants were unable to encapsi-
date the minigenome RNA due to encapsidation rather
than replication defects, we assayed encapsidation of
these mutants and some other critical mutants in a
FIG. 5. Encapsidation of intracellular negative-sense BRSV-CAT mini-
genome RNA by wild-type (WT) or mutant N proteins. Transfections
were performed as described in the legend to Fig. 3, with plasmids
encoding the wild-type or mutant N proteins, as indicated at the top.
Cells were harvested at 48 h posttransfection, and cells were lysed and
treated with MCN followed by RNA extraction. RNA was analyzed by
Northern blot hybridization, using positive-sense CAT RNA probe.nonreplicating minigenome system by omitting the BRSV
L protein in transfection. As shown in Fig. 8, deletion ofone amino acid from N terminus (lane 4) and of 28 amino
acids from C terminus (lane 10) and substitution of
leucine with alanine (lane 7) or glutamic acid (lane 8) at
position 2 ablated encapsidation, whereas deletion of 27
amino acids from the C terminus (lane 9) and substitution
of leucine with glycine (lane 5) or lysine (lane 6) left
encapsidation intact. These results indicated that the
T7-derived minigenome RNAs for mutants NND1 and
2L3A were not encapsidated into a nuclease-resistant
template due to encapsidation defect. Furthermore, com-
parison of the level of encapsidation of plasmid-derived
minigenome synthesized in a nonreplicating system ver-
sus a reconstituted system showed a low level of encap-
sidation of plasmid-derived minigenome in the nonrepli-
cating system (compare lane 1 with lane 2 in Fig. 8 and
compare lanes 5, 6, and 9 in Fig. 8 with the respective
mutants in Figs. 5A and 5B). These results have con-
firmed the earlier findings made by Fearns et al. (1997),
who worked with negative-sense RSV minigenome (C2)
and reported that the fraction of plasmid-derived mini-
genome that became encapsidated was subsequently
amplified by the RSV polymerase in the reconstituted
system.
The formation of complexes between N and P
We then investigated the interaction between the N
and P proteins using the BRSV-CAT minigenome system
described previously. Specifically, at 24 h posttransfec-
tion, cells were incubated in the presence of [35S]methi-
onine for 4–8 h, and lysates were prepared and sub-
jected to immunoprecipitation with either polyclonal
N-specific (Figs. 9A–9D) or P-specific (Fig. 9E) antiserum.
Under these conditions, P protein coprecipitated with
wild-type N protein, indicating N–P complex formation in
the transfected cells. Control experiments showed that
anti-N serum did not precipitate the P protein when the N
plasmid had been omitted (Fig. 9A, lane 3), and similarly,
anti-P serum did not precipitate the N protein when the P
plasmid was omitted (Fig. 9E, lane 3). These results
confirmed that the detection of either P or N is depen-
dent on interaction with each other. The advantage of
this assay is that interaction between N and P occurs
under conditions of reconstituted BRSV transcription and
replication and, thus, likely is a close facsimile of the
authentic situation.
Each of the N-terminal deletion mutants of the N pro-
tein formed a complex with the P protein (Fig. 9A, lanes
6–10), as did all of the leucine and cysteine point mutants
of the N protein (Fig. 9B, lanes 2–13). Each of the internal
deletion mutants formed a complex with P (Fig. 9A, lanes
11–15 and 17), except for NIDD244-290 (Fig. 9A, lane 16)
and NIDD338-384 (lane 18). This indicated that these two
regions are important for interaction with the P protein. At
the C terminus, deletion of the last 1, 2, 10, 14, 21, 22, 23,
24, 25, 26, and 27 amino acids did not inhibit the inter-
t
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222 KHATTAR ET AL.action of N with P (Figs. 9C, lanes 2–6, and 9D, lanes
1–6). However, deletion of 28 amino acids from the C
terminus completely inhibited the interaction with P (Fig.
FIG. 6. Schematic representation (not to scale) of minigenome BLT d
he 39-terminal 88 nt and 59-terminal 191 nt of the genome of BRSV stra
NC), untranslated region (UTR), gene end (GE), and trailer regions (ope
ox). The flanking plasmid sequences, including the HDV ribozyme an
polymerase at the 59 end (hatched box), are shown. Line diagram of
ribozyme self-cleavage is shown (thin line). Also shown is the predicte
version of BLT delta 7 in which a 12-nt GE signal has been inserted i
AT mRNA of 274 nt, exclusive of poly(A)1 (thick line). Nucleotide leng
FIG. 7. The synthesis of positive-sense antigenome and CAT mRNAs
and negative-sense genome RNA from the SK 7 minigenome template,
as detected by Northern blot hybridization. HEp-2 cells were infected
with MVA and transfected with SK 7 minigenome and support plasmids
encoding P, L, wild-type N, or mutant N proteins (indicated at the top)
in the same amounts as mentioned in legend to Fig. 3. Total intracel-
lular RNA was extracted at 48 h posttransfection and analyzed by
Northern blotting with positive-sense (top panel) or negative-sense
(bottom panel) CAT riboprobe.9C, lane 7). This residue is at position 364 and thus is
part of the NIDD338-384 domain mentioned earlier,
which confirms and further delineates that domain.
To further confirm the regions of N protein important
for interaction with the P protein, P-specific antiserum
was used to coimmunoprecipitate N and P protein com-
plex in the BRSV-CAT minigenome system. All of the
nd its modified derivative, SK 7. The BLT delta 7 minigenome contains
08, including the leader, gene start (GS), nonprotein coding sequence
). These sequences flank a negative-sense copy of the CAT ORF (open
e sequence at the 39 end (filled box) and the T7 promoter for T7 RNA
t BRSV-CAT minigenome after synthesis by T7 RNA polymerase and
t positive-sense CAT mRNA, exclusive of poly(A)1 (thick line). SK 7 is
AT ORF at the BspE1 site. The SK 7 minigenome encodes a subgenic
various segments are indicated.
FIG. 8. Encapsidation of intracellular negative-sense BRSV-CAT mini-
genome RNA by wild-type or mutant N proteins in the absence of BRSV
polymerase protein. Transfections were performed as described in the
legend to Fig. 3, except plasmid encoding BRSV L protein was omitted
from transfections. Plasmids encoding the wild-type (WT) or mutant N
proteins used for transfections are indicated at the top. Cells were
harvested at 48 h posttransfection and lysed and treated with MCN
followed by RNA extraction. RNA was analyzed by Northern blot hy-
bridization using positive-sense CAT riboprobe. As controls, the cells inelta 7 a
in A519
n boxes
tigenom
955 nlane 1 received plasmid encoding L protein, and those in lane 3 did not
receive plasmids encoding P and L proteins.
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223ANALYSIS OF BRSV NUCLEOCAPSID PROTEINinternal and the C-terminal 27 (NCD27) and 28 (NCD28)
amino acid deletion mutants were tested for interaction
with full-length P protein. As shown in Fig. 9E, the N
proteins with internal deletion of 244–290 (lane 11) and
338–384 (lane 13) and C-terminal deletion of 28 amino
acids (lane 14) were not coimmunoprecipitated with the
P protein, whereas all of the other internal deletions
(lanes 6–10 and 12) and C-terminal deletion of 27 amino
acids (lane 15) of the N protein did not inhibit the inter-
action with the P protein. The amount of labeled coim-
munoprecipitated N protein varied in the internal dele-
tion mutants (Figs. 9A and 9E). This variation in the
amount of labeled N protein correlated with the number
of methionine residues present in these proteins, as
these proteins were radiolabeled with [35S]methionine.
However, these proteins accumulated to levels similar to
the wild-type N protein, as demonstrated by the Western
blot developed with N-specific antiserum (Fig. 10). It was
thus concluded that a central portion, amino acids 244–
290, and a C-terminal portion, amino acids 338–364, of
the N protein are essential for N–P binding.
DISCUSSION
Studies in paramyxoviruses, such as Sendai virus,
indicate that the N protein consists of two parts: an
N-terminal conserved domain that represents three
fourths of the molecule and a C-terminal variable tail that
extends from the nucleocapsid. Other studies with Sen-
dai virus (Buccholz et al., 1993; Curran et al., 1993) and
measles virus (MV) (Bankamp et al., 1996) have shown
that N-terminal domain is important for nucleocapsid
assembly and encapsidation of RNA. The C-terminal tail
is required for association with the P–L polymerase com-
plex (Bucholz et al., 1994) and is essential for template
function while dispensable for encapsidation (Curran et
l., 1993). More recently, some of the specific residues
ithin the N-terminal domain of Sendai virus involved in
emplate function and NP–NP interactions have been
dentified, including residues within amino acids 114–129
nd 258–357 (Myers and Moyer, 1997; Myers et al., 1997).
e previously used the yeast two-hybrid system to dem-
nstrate that removal of the C-terminal 32 amino acids of
protein of BRSV inhibited the interaction with the P
rotein, whereas the removal of 32 amino acids from the
terminus had a minimal effect (Krishnamurthy and
amal, 1998). In this study, we prepared a large panel of
-terminal, C-terminal, internal deletion and substitution
utants of the BRSV N protein. Using a minigenome
ystem, we evaluated these mutants for effects on RNA
ynthesis, encapsidation, and interaction with the P pro-
ein.
Almost all of the N protein from amino acids 2–391
as required to support minigenome RNA synthesis in
RSV, whereas conservative amino acid changes were
onlethal at position 2, and cysteine residues at posi-
c
itions 156 and 162 could be changed individually but not
together. The results observed with the aforementioned
cysteine mutants indicate that it is unlikely that a disul-
fide bond involving any of these residues is obligatory for
any function of the N protein. Perhaps it is not surprising
that the integrity of nearly all of N is important for tran-
scription and replication, because these are multistep
processes. Furthermore, it must be considered that al-
terations in the N protein could cause malfolding of the
majority, if not all, of the proteins. This would indirectly
block the function of the N protein.
We examined the ability of the various N protein mu-
tants to encapsidate minigenome RNA into a nuclease
resistant structure. Deletion of up to 27 amino acids from
the C terminus resulted in only a modest reduction in
encapsidation. Overall, amino acids 1–364 were impor-
tant for encapsidation. This is consistent with our pro-
posed model, where the N-terminal body of the protein is
involved in nucleocapsid structure, whereas the C-termi-
nal tail is not. This suggests that the C-terminal tail is
quite short in the case of BRSV. However, one unex-
pected finding was that two N protein mutants (NND1
nd 2L3A), which were able to efficiently support mini-
enome CAT expression and RNA synthesis, were neg-
tive in the encapsidation assay. The fact that CAT ex-
ression and RNA synthesis were relatively efficient sug-
ests that some form of nucleocapsid was formed, but
pparently it was insufficient to protect the RNA from
uclease attack. It might be that the tight nucleocapsid
tructure that confers RNase resistance has a functional
ole, such as protection of the RNA genome, that is
istinct from and not essential for template function. In
his regard, influenza A virus also forms nucleocapsids
hat do not protect the RNA from nuclease (Kingsbury
nd Webster, 1969). The finding that nuclease-sensitive
RSV minigenome nucleocapsids can be functional, to-
ether with our previous finding that the “rule of six” does
ot apply to RSV (Samal and Collins, 1996), suggests that
RSV/BRSV might be relatively more flexible with regard
o nucleocapsid structure compared with other
aramyxoviruses.
The complex formation between the N and P proteins
as examined by radiolabeling and coimmunoprecipita-
ion, using N- or P-specific antiserum. Our results indi-
ate that amino acids 244–290 and 338–364 are critical
or forming a complex of sufficient stability to be coim-
unoprecipitated. Together with the finding described
arlier, that amino acids 1–364 were required for nucleo-
apsid formation, this study indicates that the regions
mportant for contact with P are contained within those
mportant for forming a nucleocapsid. This suggests a
odel in which the association between soluble P and N
onomers shields the region of N, which is involved inontact with RNA, and neighboring N protein monomers
n the nucleocapsid. In this way, association with P
1
B
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224 KHATTAR ET AL.prevents binding to heterologous RNA and prevents N
protein self-aggregation.
The results described here suggest that the 391-amino-
FIG. 9. Identification of BRSV N protein regions involved in interaction
as a positive control, or HEp-2 cells (in all the lanes except lane 1, pan
described in the legend to Fig. 3, and with plasmids encoding wild-ty
postinfection or transfection for 4–6 h with [35S]methionine and lysate
–D) or anti-P (panel E) serum. Under these conditions, the P protein
roteins were separated on 12% SDS–PAGE under reducing conditions.
ncoding wild-type N, P, or L proteins, respectively, and the cells in l
roteins, respectively. The mol wt markers in kDa are indicated to theacid BRSV N protein is organized somewhat like the larger
524-amino-acid Sendai virus NP protein, with an N-terminal
R
tglobular body and an short C-terminal tail (Buchholz et al.,
993; Curran et al., 1993). The N-terminal globular body of
RSV includes amino acids 1–364 and is required for both
e P protein. Btu cells (lane 1, panels A and E) were infected with BRSV
nd E) were transfected with the minigenome system components, as
utant N proteins as indicated. The cells were pulse-labeled at 24 h
processed and subjected to immunoprecipitation with anti-N (panels
ipitated due to its interaction with the N protein. Immunoprecipitated
ative controls, the cells in lanes 3–5 in panel A did not receive plasmids
–5 in panel E did not receive plasmids encoding P, L, or wild-type N
SV-specific N and P polypeptides are indicated to the right.with th
els A a
pe or m
s were
coprec
As negNA synthesis and encapsidation (Fig. 11). The C-terminal
ail, composed of amino acid residues 365–391, is not re-
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225ANALYSIS OF BRSV NUCLEOCAPSID PROTEINquired for nucleocapsid formation but is required for tem-
plate function (Fig. 11). Whether template function involves
association with viral factors, such as the L–P complex, or
with cellular factors or both is unknown. Although we stud-
ied the effect of deletion and substitution mutations of the N
protein on transcription, replication, and encapsidation of
RNA and interaction with the P protein, we have not studied
their effect on N–N interactions. Future experiments will be
required to determine their effect on these interactions and
to map N–N interacting domains.
MATERIALS AND METHODS
Cells, viruses, and antisera
HEp-2 and bovine turbinate (Btu) cells were grown in
Eagle’s minimal essential medium (EMEM) supple-
FIG. 9mented with 5% fetal bovine serum. Strain A-51908 of
BRSV was propagated in Btu cells. Modified vaccinia
1
tvirus Ankara (MVA) expressing T7 RNA polymerase (gift
from B. Moss, NIAID, NIH) was propagated in chick
embryo fibroblast cells (Wyatt et al., 1995). HEp-2 cells,
rown in 6-well culture dishes (35-mm-diameter plates),
ere used for transfections. For coimmunoprecipitation
tudies, monospecific serum raised against baculovirus-
xpressed N protein or Escherichia coli-expressed P
rotein was used.
lasmids and the mutants of N gene
Plasmids pTM1-N, pTM1-P, and pTM1-L containing
he BRSV N, P, and L genes (A51908 strain), respectively,
loned downstream of T7 RNA polymerase promoter of
lasmid pTM-1 have been described previously (Yunus
t al., 1998). Construction of the BRSV minigenome (BLT
elta 7) has been described previously (Yunus et al.,
nued998). Briefly, BLT delta 7 minigenome contains a nega-
ive-sense copy of the bacterial CAT gene under the
1
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transcription signals and flanked by the leader and trailer
regions of BRSV genomic RNA (Fig. 6) (Yunus et al.,
998). Its 39 end is generated by a self-cleaving ribozyme
rom the antigenome strand of hepatitis delta virus. The
DNA encoding minigenome SK 7 (Fig. 6) was con-
tructed from BLT delta 7 cDNA by insertion into a
nique BspE1 site within the CAT sequence of a syn-
hetic DNA containing a consensus GE motif of BRSV
Fig. 6). The synthetic DNA contained the sequence
CCGGAGTTAATAAAAATCCGGA, which is shown in the
positive sense with the GE motif underlined and the
BspE1 flanking site italicized. This GE insertion resulted
in the synthesis of a subgenic CAT mRNA of 274 nt by SK
7 minigenome construct, compared with 745-nt CAT
mRNA synthesized by BLT delta 7 construct. The 274-nt
subgenic positive-sense CAT mRNA encoded by SK7
could be easily distinguished from 955-nt BRSV-CAT pos-
itive-sense antigenome after electrophoresis on formal-
dehyde–1.5% agarose gels.
Site-specific point mutations and amino- and carboxyl-
terminal and internal deletions of the N gene of BRSV
FIG. 11. Schematic model of BRSV N protein domains. Domain I (fi
FIG. 10. Expression of wild-type or mutant BRSV N proteins in
transfected HEp-2 cells. HEp-2 cells were transfected with minigenome
system components as described in the legend to Fig. 3, with plasmids
encoding wild-type or mutant N proteins, as indicated. Cells were
harvested at 48 h posttransfection, and lysates were electrophoresed
on a 4–20% gradient gel under reducing conditions. The separated
proteins were probed in Western blotting with anti-N serum. The mol wt
markers in kDa are indicated to the left. BRSV-specific N polypeptide is
indicated to the right.encapsidation and template functions. Domain I contains the domains essenti
acids 365 to 391. It is not involved in nucleocapsid formation but is requiredwere carried out by a single round of PCR, using the
method described by Byrappa et al. (1995). Briefly, 21-mer
primers were phosphorylated at its 59 end using T4
polynucleotide kinase (New England Biolabs) at 37°C for
1 h. Then, 25 pmol of each phosphorylated internal
primer pair was used to amplify 20 ng of plasmid DNA.
Fourteen cycles of PCR amplifications were carried out
with Pfu Turbo DNA polymerase (Stratagene) (1 min at
94°C, 1 min at 55°C, and 6.5 min at 72°C). All N gene
mutants were sequenced in their entirety and confirmed
for correct N protein expression by in vitro transcription
and translation, using the rabbit reticulocyte lysate sys-
tem as described by the supplier (Promega).
Transfections
Transfections were performed as described by Gros-
feld et al. (1995). Briefly, HEp-2 monolayers in six well
plates were infected with MVA-T7 at an m.o.i. of 5 PFU/
cell and transfected with the following mixture of plas-
mids per single well by using LipoFECTAMINE plus re-
agent and LipoFECTAMINE, as described by the supplier
(Life Technologies): 0.4 mg of either BLT delta 7 mini-
genome or SK 7 minigenome DNA, 0.4 mg of either
wild-type or mutant pTM1-N, 0.2 mg of pTM1-P, and 0.1
mg of pTM1-L. Five hours later, the transfection medium
was replaced with EMEM containing 10% fetal bovine
serum. Depending on the specific experiment, cells were
harvested at 48 h posttransfection and processed for
either Western blot analysis or CAT activity or Northern
blot analysis or radiolabeled at 24 h posttransfection for
immunoprecipitation of proteins.
CAT assay
Cell pellets from individual wells were harvested by
scraping, separated into three identical aliquots, and pel-
leted by centrifugation. One of the aliquots was resus-
pended in SDS sample buffer and analyzed by Western
blotting with anti-N serum. The second aliquot was used for
extraction of total RNA for Northern blot analysis. The third
aliquot was resuspended in 200 ml of 0.25 M Tris–HCl (pH
.5), lysed by three cycles of freezing and thawing, and
larified by brief centrifugation in microcentrifuge. Aliquots
f the clarified supernatant were used to determine the total
rotein content (with a Pierce protein assay kit) and to
) extends from amino acids 1–364 and is required for genomic RNAlled box
al for binding to P protein. Domain II (hatched box) extends from amino
for template function.
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227ANALYSIS OF BRSV NUCLEOCAPSID PROTEINdetermine the CAT activity, using D-threo-(dichloroacetyl-1-
14C)chloramphenicol (50–60 mCi/mmol; Amersham) as the
substrate according to the standard procedure (Gorman et
al., 1982). Different amounts (3–20 ml) of the cell extracts
ere incubated with radioactive chloramphenicol for 2 h to
btain CAT activity values in the linear range. Quantification
f the CAT activity was done by liquid scintillation counting
f excised spots. The values obtained were corrected for
he protein concentration of the cell extract and were ex-
ressed as a percentage of the CAT activity observed for
ells expressing the wild-type N protein.
estern blot analysis
One third of the volume of the total cells harvested
rom one well was lysed in an SDS–PAGE sample buffer
ontaining b-mercaptoethanol, and lysate representing
bout 1/20th of one well of cells was subjected to elec-
rophoresis through a 4–20% gradient gel. The separated
olypeptides were transferred to nitrocellulose using
onventional techniques. BRSV-specific wild-type or mu-
ant N proteins were detected by incubation with anti-N
erum, followed by incubation with horseradish peroxi-
ase-labeled goat anti-rabbit IgG (Kirkgaard and Perry
aboratories) and by peroxidase reaction using one-
omponent TMB membrane peroxidase substrate (Kirk-
aard and Perry Laboratories).
CN protection assay
To identify encapsidated RNA, MCN protection assay
as performed according to Baker and Moyer (1988).
riefly, the cell pellet from one 35-mm well was disrupted
n 50 ml of RSB (10 mM NaCl, 10 mM Tris, pH 7.5, 1.5 mM
MgCl2)–1.0% Triton X-100/0.5% DOC–aprotinin. The clar-
ified cytoplasmic extract (3000 3 g for 15 min at 4°C),
supplemented with 50 ml of Tris–CaCl2 buffer (10 mM
ris, pH 7.5, 2 mM CaCl2), was incubated with 6 U of
MCN (Roche Molecular Biochemicals) for 30 min at
30°C. The RNA was extracted with TRIzol Reagent, ac-
cording to the supplier’s protocol.
Northern blot analysis
Depending on the specific experiment, one sixth of the
total intracellular RNA either undigested or MCN di-
gested (approximately 5–10 mg, representing one sixth of
the total amount from each well) was electrophoresed
onto 0.44 M formaldehyde, 1.5% agarose gel and trans-
ferred to nylon membrane. The RNAs were fixed at 80°C
for 1 h. Prehybridization was performed for 6 h at 65°C
with prehyb/hyb buffer (Quality Biologicals) containing
63 SSC, 53 Denhardt’s solution, 0.5% SDS, and 0.5
mg/ml sheared salmon sperm DNA. Hybridization was
performed overnight under the same conditions with
approximately 2 3 106 dpm of positive-sense or nega-
tive-sense strand-specific CAT riboprobe. To synthesize
these probes, 672-bp CAT gene, derived from PstI–XbaI-digested BLT delta 7, was subcloned in pGEM-4Z vector
(Promega), generating a plasmid pGEM4Z-CAT. Nega-
tive- or positive-sense CAT riboprobes were synthesized
by in vitro transcription of XbaI- or PstI-digested pGEMZ-
CAT DNA. The densitometric analysis of autoradiographs
of Northern blots was carried out using a densitometer
(Molecular Dynamics).
Radiolabeling of cells and immunoprecipitation
At 24 h after transfection or infection, the cells were
washed and incubated in methionine-free EMEM for 2 h
before labeling with [35S]methionine (100 Ci/ml). After 4–8
h of labeling, the cells were harvested. The cells were
lysed with radioimmunoprecipitation assay (RIPA) buffer.
Nuclei were eliminated from the lysate by centrifugation
at 10,000 rpm for 15 min at 4°C. The cytoplasmic frac-
tions were incubated overnight at 4°C with antibodies
(anti-N or anti-P serum preabsorbed with MVA-infected
HEp-2 cell lysate). Formalin-fixed killed Staphylococcus
aureus cells (GIBCO BRL), resuspended in 100 mM
NaCl–10 mM Tris, pH 7.5, 1 mM EDTA, and 1% BSA, were
added to the lysate and incubated at 4°C for 2 h. The S.
aureus cells were pelleted, and supernatants were re-
moved. The pellets were washed once with Salt Wash A
buffer (1.0 M NaCl, 0.01 M Tris–HCl, pH 7.2, 0.1% vol/vol
Nonidet P-40) and two times with Salt Wash C buffer (0.01
M Tris–HCl, pH 7.2, 0.1% vol/vol Nonidet P-40). The S.
aureus cells were then resuspended in a sample buffer
and analyzed by SDS–PAGE. Samples were incubated at
100°C for 5 min before loading onto SDS–12% polyacryl-
amide gels. Densitometric analysis of autoradiographs
of polyacrylamide gels was carried out using a densi-
tometer (Molecular Dynamics).
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